Abstract B271: A first-in-human Phase I study of ZSTK474, an oral pan-PI3K inhibitor, in patients with advanced solid malignancies.

标题
Abstract B271: A first-in-human Phase I study of ZSTK474, an oral pan-PI3K inhibitor, in patients with advanced solid malignancies.
作者
关键词
-
出版物
MOLECULAR CANCER THERAPEUTICS
Volume 12, Issue 11_Supplement, Pages B271-B271
出版商
American Association for Cancer Research (AACR)
发表日期
2014-08-15
DOI
10.1158/1535-7163.targ-13-b271

向作者/读者发起求助以获取更多资源

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started